Under the heavy blow, how can the pharmaceutical industry survive the "cold winter"?

In recent years, with the continuous deepening of the medical reform, news about layoffs and team adjustments in the medical representative industry has frequently appeared.
Many media reports have stated that more than 3 million medical representatives will disappear
.
On October 20 this year, the Central Commission for Discipline Inspection also issued a document stating that it is deeply concerned about the positive trends in the field of pharmaceutical purchases and sales
.
It mentioned that with the introduction of one after another "heavy punch" policy by the regulatory authorities, the profession of medical representatives has ushered in a special moment of "transformation or disappearance", and the era of "middlemen earning the difference" is coming to an end
.
Multiple signals indicate that medical representatives will no longer be as "infinitely beautiful" in the future as in the past.
The industry believes that the huge changes in the medical representative industry have become a certainty
.
In this context, the medical representative's course of action has also attracted the attention of the industry
.
There are persons engaged in medical representatives in nearly 8 years of foreign pharmaceutical companies, "he said state policy in recent years gradually increased the norms and constraints of the medical representatives of pharmaceutical sales explicit request for not undertake the task
.
So now frightened to do medical representatives, industry people Switched to selling insurance, some became doctor managers, and some stayed in the industry with luck.
However, under the promotion of the centralized procurement policy, if the pharmaceutical representative responsible for the centralized procurement of drugs wins the bid, he may face layoffs and unemployment.
Therefore, this industry is becoming more and more difficult to do
.
” Some analysts have pointed out that under the normalization of centralized procurement, the professional environment of medical representatives has undergone fundamental changes, and medical representatives must either switch to another career or transform
.
"In the future, medical representatives will be divided into two parts.
One is a pharmaceutical agent with high academic qualifications and strong professional ability, who will develop in the direction of medical science and drug exchange; the other is a pharmaceutical agent with strong sales ability, which will be outside public hospitals.
Pharmacies, private hospitals, and clinics are developing in the direction; in addition, pharmaceutical companies also have business-level tasks, such as channel docking, delivery and payment collection, etc.
, which also need to be undertaken by pharmacy agents
.
" From the overall trend, the pharmaceutical industry is reshuffled in It is inevitable that a large number of pharmaceutical agents will be eliminated, and pharmaceutical representatives who continue to remain in the industry will only develop in a more professional direction.

.
On September 30, 2020, the "Administrative Measures for the Recordation of Medical Representatives" issued by the State Food and Drug Administration clarified the main tasks of medical representatives, including four aspects: drafting plans and plans for the promotion of medical products; delivering medicines to medical staff Product-related information; assist the volunteers in the rational use of the company’s pharmaceutical products; collect and feed back information on the use of drugs in Linchuan and hospital needs
.
In addition, medical representatives can communicate face-to-face with medical and pharmaceutical personnel in medical institutions, hold academic conferences, lectures, provide academic materials, and conduct academic promotion and other activities through the Internet or telephone conference communication
.
Xi’an Janssen Pharmaceuticals also pointed out that there are both opportunities and challenges in the pharmaceutical industry representative industry.
In the future, pharmaceutical representatives will not disappear.
With China’s emphasis on innovative drugs and the acceleration of the speed and scope of the launch of innovative drugs, the role and value of pharmaceutical representatives will increase.
Become bigger and bigger
.
In order to cooperate with the launch of innovative drugs, pharmaceutical companies need representatives with high added value to share professional disease knowledge, drug use information, and patient management knowledge with doctors, which cannot be replaced by other tools and platforms
.
It believes that medical representatives will have a good future
.